Dark

COLL
Collegium Pharmaceutical, Inc. Common Stock
stock NASDAQ

At Close

Jul 17, 2026 3:59:59 PM EDT

36.09USD-0.496%(-0.18)316,577

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 17, 2026 9:28:30 AM EDT

36.22USD-0.138%(-0.05)264

After-hours

Jul 17, 2026 4:00:30 PM EDT

36.08USD-0.028%(-0.01)80,657

OverviewOptionsHistoricalExchangesShortsNews

Jan 3, 2022

09:46AM EST 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Dec 28, 2021

08:03AM EST Collegium Announces Settlement Framework To Resolve Pending Opioid-Related Litigation; Settlement Framework Provides For Co. To Pay Amount Not To Exceed $2.75M In Exchange For Dismissal, With Prejudice Of All 27 Pending Cases Benzinga

08:00AM EST Collegium Announces Settlement Framework to Resolve Pending GlobeNewswire Inc

Dec 6, 2021

09:30AM EST Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has been named one of the Top Places to Work in Massachusetts in The Boston Globes 14th annual employee-based survey. GlobeNewswire Inc

Nov 15, 2021

11:12AM EST Collegium Announces $25M Accelerated Buyback Benzinga

10:45AM EST Needham Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $28 Benzinga

08:30AM EST Collegium Announces $25 Million Accelerated Share Repurchase Program GlobeNewswire Inc

Nov 11, 2021

04:55PM EST Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences: GlobeNewswire Inc

Nov 8, 2021

10:00AM EST A Look Into Healthcare Sector Value Stocks Benzinga

Nov 5, 2021

09:26AM EDT Collegium Pharmaceutical Q3 EPS $0.22 Down From $0.32 YoY Benzinga

Nov 4, 2021

08:19AM EDT The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO Benzinga

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 21, 2021

04:01PM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, announced today that the Company will host a conference call and live webcast on Thursday, November 4, 2021, at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update. GlobeNewswire Inc

Oct 11, 2021

10:50AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Sep 13, 2021

08:00AM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that four poster presentations highlighting data regarding its product portfolio were presented at the Annual PAINWeek National Conference, which took place September 7-11, 2021 in Las Vegas, NV. GlobeNewswire Inc

Sep 1, 2021

04:01PM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences during the month of September: GlobeNewswire Inc

Aug 30, 2021

10:22AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Aug 16, 2021

02:32PM EDT Mid-Afternoon Market Update: Dow Turns Positive; Sesen Bio Shares Plummet Benzinga

08:00AM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that its Board of Directors has authorized the repurchase of up to $100 million of the Companys shares of common stock. GlobeNewswire Inc

Aug 6, 2021

10:16AM EDT Cantor Fitzgerald Downgrades Collegium Pharmaceutical to Neutral, Lowers Price Target to $22 Benzinga

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

06:49AM EDT UPDATE: Collegium Pharma Q2 Adj. EPS $0.27 Benzinga

06:05AM EDT Needham Maintains Buy on Collegium Pharmaceutical, Lowers Price Target to $32 Benzinga

06:04AM EDT HC Wainwright & Co. Maintains Buy on Collegium Pharmaceutical, Lowers Price Target to $28 Benzinga

Aug 5, 2021

04:34PM EDT Collegium Pharmaceutical Q2 EPS $1.79 Up From $0.23 YoY, Sales $82.94M Miss $84.77M Estimate Benzinga

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 21, 2021

04:01PM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live webcast on Thursday, August 5, 2021, at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update. GlobeNewswire Inc

Jun 25, 2021

09:18AM EDT UPDATE: Needham On Collegium Pharmaceuticals Buy Rating: Firm Highlights Growth Prospects Of Xtampza, Stability Of Nucynta To Support Overall Co. Potential For Margin Expansion, Benzinga

09:17AM EDT Needham Maintains Buy Rating On Collegium Pharmaceutical, Price Target $34. Benzinga

Jun 16, 2021

04:03PM EDT Collegium Pharma Highlights Publication Of 'Nonmedical Use of Xtampza ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment' In Journal Of Pain Research Benzinga

04:01PM EDT Collegium Announces Publication of Real-World Data in Journal of GlobeNewswire Inc

May 20, 2021

04:05PM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conference: GlobeNewswire Inc

May 6, 2021

04:20PM EDT Collegium Pharmaceutical Sees Xtampza ER Sales $155M-$165M, Nucynta Franchise Sales $185M-$195M Benzinga

04:19PM EDT Collegium Pharmaceutical Q1 EPS $0.41 Beats $0.30 Estimate, Sales $87.72M Beat $81.87M Estimate Benzinga

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 15, 2021

04:01PM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, May 6, 2021 at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update. GlobeNewswire Inc

Feb 25, 2021

04:25PM EST Collegium Pharmaceuticals Sees FY21 Xtampza ER Sales $155M-$165M And Nucynta Franchise Sale $175M-$185M Benzinga

04:25PM EST Collegium Pharmaceutical Q4 EPS $0.20 Misses $0.29 Estimate, Sales $76.27M Miss $77.41M Estimate Benzinga

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 24, 2021

10:28AM EST Collegium Pharmaceutical's Earnings Outlook Benzinga

Feb 11, 2021

04:01PM EST Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update. GlobeNewswire Inc

Feb 10, 2021

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

07:03AM EST S&P 500 To Remove TechnipFMC Post Spin-Off, Add Monolithic Power Systems Benzinga

Feb 8, 2021

07:49PM EST Monolithic Power Systems To Replace TechnipFMC In S&P 500 RTTNews

06:50PM EST Monolithic Power Systems Set to Join S&P 500; Iridium Communications to Join PR Newswire

05:18PM EST S&P Dow Jones Indices Announces 'Monolithic Power Systems Set to Join S&P 500; Iridium Communications to Join S&P MidCap 400; Collegium Pharmaceutical to Join S&P SmallCap 600' Benzinga

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

Jan 11, 2021

11:48AM EST Collegium Pharmaceuticals shares were trading higher after HC Wainwright & Co maintained its Buy rating on the stock and raised the price target from $29 to $33 per share. Benzinga

06:28AM EST HC Wainwright & Co. Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $33 Benzinga

Jan 6, 2021

04:05PM EST Collegium Issued FY21 Guidance For Its Xtampza ER Sales $155M-$165M And Nucynta Sales Of $175M-$185M Benzinga

04:01PM EST Xtampza ER Revenues Expected in the Range of $155.0 million to $165.0 million GlobeNewswire Inc

Nov 9, 2020

06:48AM EST HC Wainwright & Co. Maintains Buy on Collegium Pharmaceutical, Lowers Price Target to $29 Benzinga

Nov 5, 2020

04:40PM EST Collegium Pharmaceutical Q3 EPS $0.32 Beats $0.22 Estimate, Sales $79.18M Beat $77.43M Estimate Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Oct 26, 2020

08:06AM EDT Collegium Highlights Publication Of 'Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER' In Pain Medicine Publication Benzinga

08:00AM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced a publication titled, Postmarketing Analysis of Misuse, Abuse and Diversion of Xtampza ER, was published in the peer-reviewed medical journal, Pain Medicine. GlobeNewswire Inc

Oct 22, 2020

04:01PM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update. GlobeNewswire Inc

Sep 30, 2020

08:11AM EDT Collegium Announces Settlement with Teva Resolving Xtampza ER Patent Litigation; Collegium Will Grant Teva A License To Market Its Generic Version Of Xtampza Er In The United States Beginning On Or After September 2, 2033 Benzinga

08:00AM EDT Collegium Announces Settlement with Teva Resolving GlobeNewswire Inc

Sep 25, 2020

08:03AM EDT Collegium Pharma Appoints Rita Balice-Gordon To Board Of Directors RTTNews

08:00AM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the appointment of Rita Balice-Gordon to its Board of Directors, effective September 24, 2020. GlobeNewswire Inc

Sep 14, 2020

08:00AM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that five poster presentations highlighting data regarding its product portfolio were presented at the 14th Annual PAINWeek National Conference which took place virtually September 11-13th. GlobeNewswire Inc

Aug 5, 2020

04:01PM EDT Collegium Reports Net Income of $8.1 Million in the Second Quarter GlobeNewswire Inc

04:21AM EDT Earnings Scheduled For August 5, 2020 Benzinga

Aug 4, 2020

12:04PM EDT Collegium Pharmaceutical's Earnings: A Preview Benzinga

Jul 21, 2020

05:01PM EDT Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, August 5, 2020 at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update. GlobeNewswire Inc

Jul 14, 2020

11:20AM EDT Watching Shares Of Collegium Pharmaceuticals As Hearing BWS Financial Initiated Coverage With Sell Rating, $8 Price Target Benzinga

11:17AM EDT BWS Financial Initiates Coverage On Collegium Pharmaceutical with Sell Rating, Announces Price Target of $8 Benzinga